China Bargain-hunting Pros And Cons Of Overseas Pharmaceutical Companies - Pharmaceutical Companies,

June 15, the Ministry of Commerce spokesman Yao Jian in the day's regular press conference

that China's current economic strength is growing, increasing foreign exchange reserves, growing competitiveness of enterprises, as well as the current international market resources, commodities and some business case of falling prices for Chinese enterprises "going out" is a very important opportunity. Meanwhile, Chinese enterprises lack international experience, whether corporate culture, management capability, personnel training, or in mergers and acquisitions, the lack of sufficient experience, which is the process of globalization of Chinese enterprises have to face reality.

1: a hard bargain-hunting?? Long "big" and "present time"

Pharmaceutical enterprises in China has never been so eager?? As the global economic crisis, has been criticized, "Yen," The pharmaceutical industry began to march to go abroad, join the overseas Chinese enterprises, "buy the dips" in the ranks.

According to the world's largest financial information provider Thomson Reuters (Reuters) report released in early 2009 to February 17, at the global scale cross-border mergers and acquisitions fell 35% in the case, Chinese enterprises overseas acquisition increased by 40% year on year the total involved amounted to 21.8 billion U.S. dollars, second only to Germany, ranking second in the world.

In fact, since 2007, the global economic slowdown is increasingly clear that the Chinese economy will maintain steady growth since then, China's pharmaceutical industry, the operation of international capital had quietly rising?? 9, 2007 18 Chongqing Huiyuan Medicine 200 million Singapore dollars (about 10 million yuan), the acquisition of Singapore's second-largest chain of Chinese enterprises in Singapore new Chinese Medicine & Health Products Co., Ltd. 51% of the shares, successfully holding; January 2008 3, WuXi PharmaTech Co., Ltd. Wuxi, about 163 million U.S. dollars to complete the U.S. biopharmaceutical and medical device R & D outsourcing services, laboratory services provider Aipu Technology acquisition; March 12, 2008, China's largest The monitor manufacturer, Shenzhen Mindray, announced the acquisition of 202 million U.S. dollars in U.S. custody Datascope's life and business information, making it the world's third largest manufacturer monitor industry; the same year on April 9, listed in Hong Kong foolproof LABORATORIES Limited to 3.1175 million U.S. dollars acquisition of Nasdaq listed company CommonwealthBiotechnologiesInc. (CBI) 39% of the shares and became the largest shareholder of listed companies, and enjoy the further expansion of the stock option exercise of power.

Earlier some of the time, 39 groups have tried to East Asia through the acquisition of the Japanese pharmaceutical market to achieve its overseas expansion strategy; Hirakawa Pharmaceutical Co., Ltd. Harbin, the United States through the acquisition of listed companies Seneisente, control 96% of its equity, to successfully enter the U.S. Nasdaq.

Immediate effective operation of capital, so that more companies will this approach as a short time, "grew up" first choice. Consequently, we have getting ready to the road.

Since the end of 2008 so far, to invest in Shanghai, known for Fosun Pharmaceutical (Group) Co., Ltd. began frequent action, bargain-hunting from overseas success Haixiang Pharmaceutical Tongjitang shares to underweight, has frequently been deployed in the capital markets, stock prices performance of gratifying.

And recently, the largest manufacturer of pharmaceutical glass pharmaceutical glass Co., Ltd., Shandong Province announced the 2008 annual reports and profit distribution plan, according to annual report, the company's profits available for distribution in 2008 was 492 million, but distribution plan allocation of cash dividends to be only 15.44 million yuan. Ren Lei securities on behalf of the company, said: "In the economic downturn to invest at this time is more appropriate. Overseas markets must be done, and we are committed to expanding the international market. In China, we have developed a relatively 'monopoly' markets So now open up the overseas market is also necessary. "

Already early in the overseas distribution of the Tong Ren Tang now has 894 retail outlets, including 28 overseas stores, 17 countries around the world. Not long ago, Beijing Tong Ren Tang (Group) Co., Ltd. Mei Group, said Vice Chairman, Tong Ren Tang is likely the near future to buy properties overseas, prepare for further expansion.

The Ministry of Commerce recently released, "Foreign Investment and Cooperation countries (regions) Guide" (hereinafter "Guide") involving the countries and regions have expanded to 162. Zhefen directly used to guide Chinese enterprises to take the initiative to actively enter the international market guidance document is rich in content, both the countries and regions presented with basic information about investment and cooperation, but also to the Chinese enterprises doing business in these countries and regions may be problems were prompt, and give enterprises the necessary recommendations. Relevant national and regional laws and regulations, official statistical data and other political, economic and social development of the situation also in the "Guide" on some show.

From the Ministry of Commerce Web site indicates, "Guide" published before the day of the channels in the 10,000 page views to 1.5 million, whilst the figure in the "Guidelines," rose quickly after release, to the end of June , has risen to 15 million or more.

Department of Commerce statistics, the past two years, China's Overseas M & A momentum rapidly, has grown from 200 million U.S. dollars in 2002 up to 2008's 20.5 billion U.S. dollars, accounting for 50% of the total foreign investment. M & A focus on energy, mining, manufacturing, trade, service and other fields.

Commerce Department official pointed out, the financial crisis spread to developed countries, severely damaged the financial system and capital strand breaks enterprises need foreign investment and aid. At the same time, the financial crisis has prompted many industries in many countries the international division of labor and investment policies have been adjusted to control the original on foreign policy, will have varying degrees of loosening. Thus, it is our business "going out" for the acquisition, through "buy the dips" a good opportunity to rapidly grow.

by: gaga

POST COMMENT

China Diagnostic Reagent Industry Report, 2010 Mv Monte Cervantes - China Crane Wafer Check Valve - Wafer Type Check Valve Manufacturer Facts That Help You Make Your Journey To China Pleasing Reese - Stone Texture Manufacturer - China Seamless Stone Texture October Dreams - Flange Manufacturer - China Pneumatic Actuator Pe Prices In China Decline For The Third Consecutive Week-pe, Polyethylene - Plastics Industry 2008 Chronology Of China's General Supplies Industry Events - General Supplies, Office Supplies Liu Liangchen: Loader Industry In China Challenges And Opportunities - Loader, Liu Liangchen - Apelles - China Wafer Type Butterfly Valve - Butterfly Valve Manufacturer Manufacturer UL certified cable ties from China China's footwear exports to the "four difficult" situation Car Tire Prices Of Raw Materials Soared Chongqing 3% -5% Price Increase - China Rubber And Leather Coolmax - Stone Texture Manufacturer - China Tileable Stone Texture